← Back to headlines
BNP Paribas Downgrades Sanofi Due to Unlikely Near-Term Rerating
BNP Paribas has downgraded Sanofi, citing an unlikely near-term rerating for the pharmaceutical company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
